Nirvana Life Sciences Inc (TSE:NIRV)
CNQX:NIRV
Canadian Market
Holding TSE:NIRV?
Track your performance easily

Nirvana Life Sciences Inc (NIRV) Financial Statements

5 Followers

Nirvana Life Sciences Inc Financial Overview

Nirvana Life Sciences Inc's market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; Nirvana Life Sciences Inc is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jan 24Oct 23Jul 23Apr 23Jan 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ 5.02KC$ -168.73KC$ -360.83KC$ -699.97KC$ -234.68K
EBITDAC$ 17.23KC$ -168.73KC$ -360.83KC$ -677.06KC$ -211.77K
Net Income Common StockholdersC$ 5.37KC$ -168.39KC$ -360.98KC$ -704.14KC$ -234.14K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 3.14KC$ 9.64KC$ 41.46KC$ 12.49KC$ 4.29K
Total AssetsC$ 211.76KC$ 61.85KC$ 92.14KC$ 68.57KC$ 392.90K
Total DebtC$ 23.62KC$ 21.66KC$ 8.03KC$ 58.40KC$ 83.06K
Net DebtC$ 20.49KC$ 12.02KC$ -33.42KC$ 45.91KC$ 78.76K
Total LiabilitiesC$ 1.03MC$ 912.01KC$ 844.83KC$ 1.01MC$ 941.02K
Stockholders EquityC$ -812.35KC$ -845.86KC$ -748.74KC$ -936.35KC$ -546.73K
Cash Flow-
Free Cash FlowC$ -8.46KC$ -70.45KC$ -105.07KC$ -68.68KC$ -24.85K
Operating Cash FlowC$ -8.46KC$ -70.45KC$ -105.07KC$ -68.68KC$ -24.85K
Investing Cash Flow-----
Financing Cash FlowC$ 1.96KC$ 38.63KC$ 134.04KC$ 76.88KC$ 23.37K
Currency in CAD

Nirvana Life Sciences Inc Earnings and Revenue History

Nirvana Life Sciences Inc Debt to Assets

Nirvana Life Sciences Inc Cash Flow

Nirvana Life Sciences Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis